ArticleCancers2026

MRI-Based Delta Necrosis as a Prognostic Marker Following Neoadjuvant Chemotherapy in Soft Tissue Sarcoma.

Harold Bravo Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.